Bio-Rad launches first ultrasensitive multiplexed digital PCR assay for breast cancer mutation detection in clinical research

FHS
April 3, 2024
4:16 am

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit.

New Two-Tier System to Weed Out Some Pediatric Heart Surgery Centers

Professional societies agreed that U.S. centers performing pediatric and congenital heart surgery should be formally reorganized into two tiers with volume requirements designed to maintain

September 30, 2023

Stryker inks Artelon buyout to join Zimmer in soft tissue space

Dive Brief: Stryker said Monday it has agreed to buy Artelon for an undisclosed sum to add soft tissue repair technology to its portfolio. The

June 4, 2024

MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Conference MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference 08.01.2024 / 08:00 CET/CEST The issuer is

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.